Yuxin Zhang

ORCID: 0000-0001-7224-2533 · 3 papers in corpus · active 2022-2024

Study types

  • article 2
  • other 1

Condition tags

  • endometriosis 3
other 2024
Macranthoidin B restrains the epithelial-mesenchymal transition through COX-2/PGE2 pathway in endometriosis
Frontiers in pharmacology ·doi:10.3389/fphar.2024.1492098

INTRODUCTION: Macranthoidin B is one of the primary and unique triterpenoid saponin metabolites from Lonicera macranthoides Hand. -Mazz, which is used to treat endometriosis (EMS) in traditional Chinese medicine. However, the effect of macr…

article 2023
Ferulic acid, ligustrazine, and tetrahydropalmatine display the anti-proliferative effect in endometriosis through regulating Notch pathway
Life sciences ·doi:10.1016/j.lfs.2023.121921

AIMS: With an ambiguous anti-proliferative mechanism, the combination of ferulic acid, ligustrazine, and tetrahydropalmatine (FLT) shows good anti-endometriosis (EMS) activity. In EMS, the expression of Notch pathway and its role in prolife…

article 2022
Analysis of Adverse Events and Medical Errors in Long-Term Hormone Treatments for Endometriosis: A Study Based on the US Food and Drug Administration Event Reporting System
International journal of women's health ·doi:10.2147/ijwh.s377418

PURPOSE: To investigate adverse events and medical errors, as well as their possible risk factors, of combined oral contraceptives and progestins used in patients with endometriosis. PATIENTS AND METHODS: Reports between January 1, 2014 an…